Somatostatin Binding in Gastrointestinal Cancer
Author Information
Author(s): G.V. Miller, S.M. Farmery, L.F. Woodhouse, J.N. Primrose
Primary Institution: University Department of Surgery, St. James's University Hospital
Hypothesis
The study aims to investigate somatostatin binding in human gastrointestinal cancer and normal mucosa.
Conclusion
The study found that low affinity, high capacity somatostatin binding is common in both gastrointestinal tumors and normal mucosa.
Supporting Evidence
- Specific somatostatin binding sites were found in 23 out of 28 gastric cancers and 17 out of 23 colonic cancers.
- Low affinity binding was demonstrated in normal mucosal samples.
- One gastric carcinoma exhibited high affinity receptors for somatostatin.
Takeaway
This study looked at how a substance called somatostatin sticks to cancer and normal cells in the stomach and intestines, finding that it sticks in a similar way to both.
Methodology
Plasma membranes were prepared from tumor and normal mucosa specimens, and somatostatin binding was assessed using a competitive displacement assay.
Limitations
The functional significance of the low affinity binding sites is unclear, and only one tumor expressed high affinity receptors.
Participant Demographics
26 male and 25 female patients with a mean age of 70.4 years.
Want to read the original?
Access the complete publication on the publisher's website